Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo.
about
Sustained translational repression by eIF2α-P mediates prion neurodegenerationHeat shock factor 1 regulates lifespan as distinct from disease onset in prion disease.Cytoplasmic prion protein induces forebrain neurotoxicityContext dependent neuroprotective properties of prion protein (PrP).A highly toxic cellular prion protein induces a novel, nonapoptotic form of neuronal deathEngulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.Activation of pro-survival CaMK4β/CREB and pro-death MST1 signaling at early and late times during a mouse model of prion disease.The intricate mechanisms of neurodegeneration in prion diseases.Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways.Striatal pathology underlies prion infection-mediated hyperactivity in mice.Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis.Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection.The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration.Degenerating synaptic boutons in prion disease: microglia activation without synaptic strippingSynaptic dysfunction in prion diseases: a trafficking problem?Prion pathogenesis is independent of caspase-12.All quiet on the neuronal front: NMDA receptor inhibition by prion protein.Prion protein lacks robust cytoprotective activity in cultured cells.What Is Our Current Understanding of PrPSc-Associated Neurotoxicity and Its Molecular Underpinnings?
P2860
Q24602153-0D5FBBF3-C929-40AA-BD2F-CA677A5447E6Q30483457-56A61E37-50D0-4A1C-AD20-5D428F9F834FQ30488090-D6B0D3A9-B32F-4F4D-8F8F-0DEA82273FD4Q33595425-DB04C096-3577-4A2A-94C5-F5E085D31F07Q33882410-029CB777-C875-4E3F-8903-F496D475D3B5Q34161546-17C1610E-A8AB-4CAE-BCAD-7F5007AAD235Q34207678-F02518AD-0BC8-4F20-8D0E-07104BCD5113Q34664576-99E21936-EEF1-4C4C-8E4A-4809682F1AA3Q35566835-45A6BD38-AFAB-47CF-AABE-DCF79602CD30Q35714160-074789C2-1CDA-49B1-8515-91C6DD326AC9Q36393034-22BDBA44-E0A9-490C-8811-B874B897759CQ36981826-825F1A07-B58B-46C8-929E-0186B0EA4AEDQ37326706-16A4D7A6-840F-4AF9-8A11-4086EF9B885DQ37362101-605E0D51-B75B-41B9-A010-C23018367375Q37393121-664C2DF9-55A3-4D64-AEDF-393C0DC20477Q42068269-18C64253-1681-4D5A-A485-B16719380699Q42091975-94F34BE9-A691-45A1-8826-226F67330FDCQ42745830-62F529FC-2958-40E0-AE66-A5C54820FCC9Q47342598-9F4F314D-0495-4AFD-8662-CEE0AE567784
P2860
Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Diminishing apoptosis by delet ...... ctious prion toxicity in vivo.
@en
type
label
Diminishing apoptosis by delet ...... ctious prion toxicity in vivo.
@en
prefLabel
Diminishing apoptosis by delet ...... ctious prion toxicity in vivo.
@en
P2093
P2860
P1476
Diminishing apoptosis by delet ...... ctious prion toxicity in vivo.
@en
P2093
Andrew D Steele
Andrew W Borkowski
Claudio A Hetz
Oliver D King
Peter Thielen
Robert Wollmann
Walker S Jackson
P2860
P304
13022-13027
P356
10.1523/JNEUROSCI.3290-07.2007
P407
P577
2007-11-01T00:00:00Z